Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives. - Heyrman B; Meers S; Sid S; Put N; Theunissen K; Van Eygen K; De Beule N; Clauwaert M; Maes H; Salembier A; Lemmens J; Velde AV; et al. (EJHaem, 2024)